Case | Age | Sex | Lesion location | Comorbidity | Risk factor | Treatment | Outcome | Ref |
---|---|---|---|---|---|---|---|---|
1 | 69 | F | Colon | RA | MTX | ND | ND | 2 |
2 | 53 | F | Colon, Rectum | CD | MTX, Infliximab | Dose reduction | Development of HL | 7 |
3 | 75 | F | Esophagus | RA | AZA | Dose reduction | Improvement | 2 |
4 | 63 | M | Anus | CD | AZA | Dose reduction | Improvement | 5 |
5 | 81 | F | Colon | ITP | AZA | Surgical resection | Death by LPD | 3 |
6 | 26 | M | Rectum | CD | AZA, Infliximab | Surgical resection | Improvement | 12 |
7 | 78 | M | Rectum | UC | CyA | Dose reduction | Improvement | 2 |
8 | 64 | F | Colon | HSCT | CyA | Dose reduction | Improvement | 2 |
9 | 61 | M | Esophagus | Organ transplant | MMF | Dose reduction | Improvement | 4 |
10 | 70 | M | Rectum | Organ transplant | MMF | Dose reduction, Rituximab adm | Improvement | 4 |
11 | 32 | M | Terminal ileum | Organ transplant | MMF, Tac | Dose reduction, Rituximab adm | Improvement | 4 |
12 | 61 | F | Esophagus | PID | immune deficiency | Rituximab adm, IVIG adm | No change | 6 |
13 | 64 | F | Cecum | None | Age | Surgical resection | Improvement | 11 |
14 | 81 | M | Colon | CKD | Age | Surgical resection | Improvement | Our case |